President, Regenerative Medicine & Biologics Innovation · MIMEDX GROUP, INC. (MDXG)

Robert Stein

A named executive officer of MIMEDX in every fiscal year CompBrief holds from FY2020 to FY2022. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$1,739,283

Salary $516,154Stock awards $1,099,999

FY2021: $1,831,246

3rd of 5 named executive officers at Mimedx by FY2022 total.

5 named officers on file for MIMEDX, FY2022

Robert Stein’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 4 equity grants, each cited to its filing
  • MDXG’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how MIMEDX’s whole pay program stands against its peers

  • MIMEDX’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on MDXG→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed May 15, 2023 (DEF 14A).

Free

Get Robert Stein’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Robert Stein compensation by year

MIMEDX Summary Compensation Table · all 3 fiscal years held
In US dollars, as MIMEDX reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021FY2022
Salary$192,308$500,000$516,154
Bonus$250,000$0$0
Stock awards$500,000$1,099,996$1,099,999
Option awards$0$0$0
Non-equity incentive$83,334$222,500$115,050
Pension and deferred compensation$0$0$0
All other$316,741$8,750$8,080
Total$1,342,383$1,831,246$1,739,283

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: MIMEDX GROUP, INC. DEF 14A filed May 15, 2023, accession 0001140361-23-024514, and prior-year filings. Open the filing on EDGAR.

How this page was built: the MIMEDX GROUP, INC. filed document, accession 0001140361-23-024514. Every figure is read from that document and cited to the page and table it appears in. Filed May 15, 2023.

$1.3M
$1.8M
$1.7M
FY20
FY21
FY22
SalaryBonusNon-equity incentiveStock awardsAll other

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
RSU279,393$776,713—
PSU59,524$165,477—

Per the Outstanding Equity Awards at Fiscal Year-End table in MIMEDX GROUP, INC.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.

MIMEDX’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Peter CarlsonEVP - Finance and Chief Financial Officer$1,851,397
William Hulse IVGeneral Counsel and Chief Administrative Officer$1,777,363
Robert Stein · this pagePresident, Regenerative Medicine & Biologics Innovation$1,739,283
Rohit KashyapFormer President, Wound Care & Surgical$1,726,334
K. Todd NewtonInterim Chief Executive Officer$1,172,121

The full MIMEDX compensation record

free company brief

This page is one person within MIMEDX's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the MIMEDX proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are MIMEDX's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Robert Stein's compensation dossier · One-time report. No refunds.